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ABSTRACT 
Background: This study compared outcomes of combined toric versus spherical intraocular lens (IOL) implantation in patients with low 
corneal astigmatism. 
Methods: In this retrospective contralateral study, patients with corneal astigmatism who received combined toric (FIL 611 T, Soleko, 
Rome, Italy) and spherical IOL (FIL 611 T, Soleko, Rome, Italy) implants were recruited. Eyes were examined preoperatively and then 
again 3 months postoperatively. Postoperatively, uncorrected distance visual acuity (UCDVA), residual astigmatism, and spherical 
equivalent (SE) were compared between the toric IOL-implanted eyes and the spherical IOL-implanted fellow eyes. 
Results: Among the 46 included cases (age 69 ± 12.7 years [mean± standard deviation]; range: 60‒78 years), 86.9% of eyes (n = 40) in 
the toric IOL group had a postoperative refractive cylinder of ≤ 0.25 diopters (D), compared with 4.3% (n = 2) of eyes in the spherical 
IOL group. Both groups showed a statistically significant reduction in refractive cylinder and improvement in UCDVA after cataract 
surgery (both P = 0.01). Similarly, toric IOLs were superior (69.6%) to spherical lenses (2.2%) in obtaining a SE of ≤ 0.25 D. 
Conclusions: To our knowledge, no previous study had sought to compare low-power toric and spherical IOLs in low corneal 
astigmatism in the same patient's eyes. Our findings suggest that low-power toric IOLs may result in good refractive outcomes as 
compared with spherical IOLs implanted in the fellow eye of the same patient, although both result in significant UCDVA improvement. 
Well‐designed clinical research studies with a longer follow-up and more participants are necessary to confirm these findings. 
KEY WORDS   
cataract, toric IOL, spherical IOL, intraocular lenses, astigmatism, cornea, cataract surgery 
Copyright © 2020, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-
Non Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and 
redistribute the material just in noncommercial usages, provided the original work is properly cited. 
Correspondence to: Valeria Albano MD, Department of Basic Medical Sciences, Neurosciences and Sense Organs, Institute of Ophthalmology, University 
of Bari, Italy. Postal address: Piazza Giulio Cesare 11, 70124 Bari, Italy. E-mail: valeria.albano12@gmail.com  
How to cite this article: Albano V, Sborgia A, Palmisano C, Alessio G. Combined implantation of toric and spherical intraocular lenses for low corneal 
astigmatism correction. Med Hypothesis Discov Innov Optom. 2020 Winter; 1(3): 118-123. DOI: https://doi.org/10.51329/mehdioptometry116 
INTRODUCTION 
The cornea is the main optical surface of the eye. It has a 
central thickness of about 550 micrometers (μm) and vertical 
and horizontal diameters of about 11.5 millimeters (mm) and 
12.5 mm, respectively [1]. It is responsible for two-thirds of 
ocular refractive power, while the remaining one-third is 
attributable to the crystalline lens [2].  
The corneal surface shows much refractive astigmatism 
[3], as it has a toroidal shape [4]. Total corneal astigmatism 
is defined as the sum of the anterior and posterior 
surfaces [5]. Corneal astigmatism is classified, according to 
the axis of astigmatism, as being either with-the-rule, 
oblique, or against-the-rule, and this classification is very 
useful for clinical investigation [6]. Although the sum of 
both the corneal astigmatism (anterior and posterior 
corneal astigmatism) and lenticular astigmatism (internal 
astigmatism) is known as total or refractive astigmatism 
[7]. However, we refer to astigmatism as corneal 
astigmatism in this report.  
Intraocular lens (IOL) implantation following cataract 
surgery should compensate for refractive astigmatism, 
particularly that of the cornea, which can be marked [8]. 
Astigmatism correction using toric IOLs is an effective 
option [9]. Toric IOLs were introduced by Shimizu et al. in 
1992 as three-piece, non-foldable, polymethyl 
methacrylate implants to be inserted through a 5.7-mm 
incision [10]. Toric IOLs are single-vision, folding, non-
symmetric lenses and entail power measurement based 
on at least two different meridians [11]. Standard toric 
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IOLs are designed to correct preexisting corneal 
astigmatism ranging from 1.00 diopter (D) to 4.75 D [12].  
It is not always easy to establish what amount of corneal 
astigmatism should be corrected. This study investigated 
the outcomes of combined toric surgery in patients with 
low degrees of corneal astigmatism as compared with 
those of fellow eyes implanted with spherical IOLs. 
METHODS   
In this retrospective contralateral study, we performed 
consecutive evaluations of medical records from 
September 2019 to August 2020 to select patients whose 
eyes were within 1.00 D of corneal astigmatism, who 
underwent cataract surgery at the Eye Clinic of Polyclinic 
University Hospital of Bari, Italy. We included eyes with no 
previous refractive surgery, no corneal pathology, and 
presumably uncomplicated cataract surgery. Subjects 
with other ocular or systemic diseases, such as corneal 
disease, glaucoma, uveitis, retinopathy, diabetes mellitus, 
hypertension, or undergoing some secondary treatment 
(IOL repositioning or refractive surgery) were excluded. 
Routine preoperative assessments included anterior and 
posterior segment examination using slit lamp 
examination, intraocular pressure (IOP) measurement by 
Goldmann applanation tonometry, and optical coherence 
tomography (OCT) imaging, for both eyes of the study 
subjects. The data were treated in accordance with the 
tenets of the Declaration of Helsinki. All participants 
signed an informed consent form before surgery. Ethical 
approval for the study was obtained from the 
Interregional Ethics Committee, located in Policlinico di 
Bari - P.zza G. Cesare n. 11, Bari- 70124 (n.5135). 
The preoperative spherical IOL power was measured via a 
biometric algorithm, using the Holladay formula for eyes 
with an axial length (AL) between 22.00 and 26.00 mm, 
the SRK/T formula with an AL ≥ of 26.00 mm, and the 
Hoffer Q formula with an AL ≤ 22.00 mm [13]. 
Preoperative toric IOL calculations were performed using 
the biometric data for the Barrett Toric calculator, which 
is a standardized system of calculation that accounts for 
the amount of posterior corneal astigmatism [14]. The 
spherical power of the IOL was calculated by assuming 
that the mean keratometry (K) value was equivalent to the 
K value of the steepest meridian and by using the standard 
equations for IOL power calculation. The spherical power 
was also calculated assuming a mean K value equivalent 
to that of the flattest meridian. The difference between 
the spherical power obtained from the steepest and 
flattest K values represents the astigmatic power of the 
implant required [15]. 
A single surgeon performed all surgeries (G.A.) as a 
sequential bilateral cataract surgery with a 1-month 
interval. The corneal cut was located at 180° in the right 
eye and 0° in the left eye. For eyes planned to be 
implanted with a toric IOL, the steepest axis was identified 
using an image-guided system (Callisto eye; Carl Zeiss 
Meditec AG, Jena, Germany).   
Each patient received a toric IOL (FIL 611 T¸ Soleko, Rome, 
Italy) in one eye, and a spherical IOL (FIL 611, Soleko, 
Rome, Italy) in the fellow eye, and the outcomes between 
eyes were compared. The choice of eye that received the 
toric IOL or spherical IOL was independent of biometric 
characteristics. Patients were informed which eye 
received the toric IOL and spherical IOL. Postoperative eye 
drops were similar for both eyes including nonsteroidal 
anti-inflammatory (indomethacin 0.5 mL, 0.5 %, Indom®, 
Alfa Intes, Naples, Italy, 3 times daily), a fixed-combination 
antibiotic corticosteroid (betamethasone 0.2% + 
chloramphenicol 0.5%, Betabioptal®, Thea Farma, Milan, 
Italy, 3 times daily), and hyperosmolar ophthalmological 
solution (sodium chloride 5% + hyaluronic acid 0.15%, 
ODM5®, Ascoli Piceno, Italy), with the same frequency for 
both eyes. The preoperative biometric data for each eye 
were acquired using the IOL Master 700 (Carl Zeiss 
Meditec AG, Jena, Germany). Biometry assessed the AL 
and K readings and anterior chamber depth (ACD). The 
preoperative and 3-month postoperative evaluations 
included uncorrected distance visual acuity (UCDVA), 
employing the logarithm of the minimum angle of 
resolution (logMAR) visual acuity chart, and manifest 
refraction using a Nidek AR-1 Auto Refractometer (Nidek 
Co, LTD, Aichi, Japan). Postoperative residual astigmatism 
and spherical equivalent (SE) were considered as the final 
refractive outcomes. Preoperative estimation of 
postoperative refractive data was indicated as the 
estimated outcome, while the 3-month postoperative 
follow-up refraction results were considered as the actual 
outcome. 
Statistical analyses were performed using SPSS Statistics 
for Windows (version 23.0; IBM Corp., Armonk, NY). The 
Wilcoxon signed-rank test was used to compare 
preoperative and postoperative data, and the Mann‒
Whitney U test was used for comparison between groups. 
Categorical comparisons of postoperative outcomes were 
made using Pearson’s chi-squared test. Statistical 
significance was assumed at P < 0.05. 
RESULTS  
The study identified 96 eyes of 48 patients in the specified 
period with the relevant planning and postoperative 
refractive data available. Four of these eyes (4.2%) were 
excluded after cataract surgery because of misalignment, 
leaving 92 eyes for analysis, including 46 toric IOL-
implanted eyes and 46 spherical IOL-implanted eyes. 
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Misalignment resulted in a reduction of refractive 
outcomes: the mean ± standard deviation (SD) of IOL 
misalignment was 11.3 ± 4.8 degrees, the mean estimated 
reduction in astigmatic correction was 0.65 ± 0.45 D, and 
the actual reduction was 0.95 ± 0.42 D, resulting in 
undercorrection of refractive error.  
The age range of the 46 included cases was 60‒78 years 
(mean ± SD: 69 ± 12.7 years). Of the 92 eyes selected, 56 
had with-the-rule and 40 eyes had against-the-rule 
astigmatism. The demographic characteristics and 
preoperative biometric data of the study participants are 
summarized in Table 1. The baseline data, including 
preoperative UCDVA, AL, ACD, and mean K were not 
statistically significantly different between the two groups 
(P-values > 0.05) (Table 1). 
Postoperatively, no ocular complications were observed, 
and no binocular symptoms or image distortion were 
reported by the study subjects. Table 2 summarizes the 
mean ± SD of pre- and postoperative UCDVA, 
postoperative estimated and actual SE, and postoperative 
estimated and actual refractive astigmatism in both study 
groups. The mean ± SD of UCDVA improved significantly in 
the toric IOL group and in the spherical IOL group (both P 
< 0.01) by 3 months postoperatively, with no significant 
differences between them (P = 0.33). The actual and 
estimated postoperative SE were not significantly 
different in the toric IOL group (P = 0.65), while the actual 
postoperative SE was significantly higher than the 
estimated postoperative SE in the spherical IOL group (P < 
0.01). The actual postoperative refractive astigmatism 
was significantly lower than the estimated value in the 
toric IOL group (P < 0.01). However, there was no 
significant difference between the actual and estimated 
postoperative refractive astigmatism in the spherical IOL 
group (P = 0.1). The actual postoperative SE and refractive 
astigmatism were significantly lower in toric IOL group 
than the spherical IOL group (both P = 0.01) (Table 2).  
Of the eyes implanted with toric IOLs, 32 (69.6%) and 13 
(28.3%) were within ± 0.25 D and ± 0.50 D of the actual 
postoperative SE, respectively. A lower percentage of eyes 
implanted with spherical IOLs were within ± 0.25 D (1 
[2.2%]) and ± 0.50 D (19 [41.3%]) of the actual SE. The 
percentage of eyes within ± 0.25 D and ± 0.50 D of the 
actual SE was significantly higher for the toric IOL group (n 
= 45; 97.8 %) than for the spherical IOL group (n = 20; 
43.5%) (chi-squared test, P = 0.01). Of the eyes implanted 
with toric IOLs, 40 (86.9%) and 5 (10.9%) were within ± 
0.25 D and ± 0.50 D of the actual postoperative refractive 
astigmatism, respectively. A lower percentage of eyes 
implanted with spherical IOLs were within ± 0.25 D (2 
[4.3%]) and ± 0.50 D (20 [43.5%]) of actual postoperative 
refractive astigmatism. The percentage of eyes with 
residual refractive astigmatism ≤ ± 0.50 D was significantly 
higher in toric IOL-implanted eyes (n = 45; 97.8%) than in 
those with spherical IOL (n = 22; 47.8%) (P = 0.01). 
Table 1. Demographic characteristics and preoperative data of the study participants in both groups. 
Characteristics Toric IOL Group Spherical IOL  Group P-value 
Eyes, n (OD/OS, total) 22/26, 48 25/23, 48 - 
Age in 46 included cases, Y (mean ± SD) 69.1 ± 8.9 - 
Sex, n (M/F) 27/21, 48 - 
AL (mm), mean ± SD 23.25 ± 2.87 23.70 ± 2.45 0.35 
ACD (mm), mean ± SD 3.2 ± 0.43 3.4 ± 0.52 0.20 
Mean-K (D), mean ± SD 44.50 ± 1.00 44.25 ± 1.25 0.11 
Pre-UCDVA (logMAR) 0.78 ± 0.26 0.75 ± 0.28 0.40 
Abbreviations: IOL, intraocular lens; OD, right eye; OS, left eye; SD: standard deviation; n, number; M, male; F, female; AL, axial length; ACD, anterior 
chamber depth; Y, years; mm, millimeters; D, diopter; Estimated DC, estimated post-operative refractive cylinder; Pre-UCDVA, preoperative uncorrected 
distance visual acuity in LogMAR notation; LogMAR, Logarithm of the Minimum Angle of Resolution. (Mann-Whitney U test) 
 
Table 2. Comparison of preoperative and 3-month postoperative UCDVA, SE, and refractive astigmatism of the two study groups.  
Variable Toric IOL Group Spherical IOL  Group P-value 
Preoperative UCDVA (logMAR) , mean ± SD 0.78 ± 0.26 0.75 ± 0.28 0.40 
Postoperative UCDVA (logMAR) , mean ± SD 0.14 ± 0.12 0.20 ± 0.14 0.33 
P- value < 0.01 < 0.01  
Estimated Postoperative Refractive SE, (D) , mean ± SD -0.25 ± 0.75 -0.15 ± 0.80 0.30 
Actual Postoperative Refractive SE, (D) , mean ± SD -0.20 ± 0.05 -0.55 ± 0.16 0.01 
P- value 0.65 < 0.01  
Estimated Postoperative Refractive Astigmatism, (D) , mean ± SD -0.81 ± 0.33 -0.78 ± 0.36 0.40 
Actual Postoperative Refractive Astigmatism, (D) , mean ± SD -0.15 ± 0.23 -0.63 ± 0.42 0.01 
P- value < 0.01 0.10  
Abbreviations: UCDVA, uncorrected distance visual acuity in LogMAR notation; LogMAR, Logarithm of the minimum angle of resolution; SE, spherical 
equivalent; IOL, intraocular lens; D, diopter. Wilcoxon test for preoperative and postoperative data, Mann‒Whitney U test for comparison between 
groups (P < 0.05 is shown in bold) 
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DISCUSSION  
The demographic and preoperative data of the two groups 
were similar. Three months postoperatively, UCDVA 
improved significantly in both groups, with no significant 
differences between them. The number of eyes with 
postoperative refractive outcomes within ± 0.25 D and ± 
0.50 D of the actual SE in the toric group was higher than 
that in the spherical IOL group. 
IOL implantation in cataract surgery aims to achieve 
effective results in terms of refractive outcome, spectacle 
independence, and patient expectation [16]. Choosing a 
spherical lens in low corneal astigmatism does not always 
obtain the expected refractive outcome and consequent 
patient satisfaction, while a low-power toric lens may 
prove to be more effective in achieving the required 
refractive result [17]. However, more precise 
individualized IOL power selection requires valid methods 
for predicting the magnitude and axis, as well as the 
alignment of the toric IOL during surgery [10]. 
Toric IOLs are commonly recommended in cases with 
significant preoperative corneal astigmatism of ≥ 1.5 D. 
Most of the comparison studies between toric and 
spherical lenses have been carried out on eyes with high 
corneal astigmatism (≥ 2 D) [18-26]. However, only a few 
studies have compared eyes with low corneal astigmatism 
(< 1.5 D) implanted with toric and spherical lenses [27]. To 
our knowledge, no previous study has sought to compare 
refractive outcomes of toric and spherical IOLs in fellow 
eyes of the same patient with corneal astigmatism ≤ 1 D. 
In the current study, more eyes implanted with toric IOLs 
than with spherical IOLs achieved SE and refractive 
astigmatism within ± 0.25 D, while UCDVA was not 
significantly different.  
Statham et al. [28] obtained a significant (P = 0.01) 
improvement in UCDVA with toric IOLs around 1 D 
(logMAR 0.046) as compared with spherical IOLs (logMAR 
0.278). Although, in the current study, UCDVA was not 
significantly different between groups (P = 0.33), we found 
a significant improvement in both groups (P = 0.01) by 3 
months postoperatively.  
Mairot et al. [29] observed very good refractive outcomes 
in terms of residual astigmatism (SE ± 0.50 D) with both 
low-power (0.43 D) and medium-power (0.27 D) toric IOL 
implantation. Levitz et al. [30] analyzed the postoperative 
refractive data following implantation of low-power toric 
IOLs in patients with corneal astigmatism < 1.25 D and 
found a significant reduction in postoperative refractive 
cylinder (< 0.25 D, P = 0.001). Likewise, our results showed 
that the postoperative actual refractive astigmatism value 
(-0.15 ± 0.23 D) was far less than the estimated value (-
0.81 ± 0.33 D) in the toric IOL group.  
It is advised to aim for residual astigmatism < 0.50 [31] and 
SE refraction within ± 0.5 D in the majority of patients in 
order to achieve spectacle independence [27]. Moreover, 
Buscacio et al. [32] have proven that a change from a 
mean postoperative corneal astigmatism of -1.06 ± 0.27 D 
to -0.34 ± 0.39 D correlated with an improvement in 
patients’ quality of life. In line with this, the percentage of 
eyes within ± 0.25 D and ± 0.50 D of the actual spherical 
correction were significantly higher for the toric than for 
the spherical IOL group in our study. Likewise, the 
percentage of eyes with residual refractive astigmatism ≤ 
± 0.50 D was significantly higher in eyes implanted with 
toric IOLs than in eyes implanted with spherical IOLs.  
The present study had the following strengths. First, 
although previous studies have already looked into the 
differences in IOL sphere and cylinder power and 
orientation [33-35], no previous study had examined eyes 
with a degree of corneal astigmatism less than 1 D or 
compared the implantation of the two different IOLs in the 
eyes of the same patient. Second, using data from the two 
eyes of the same patient, the current study provided a 
clinically relevant examination between the postoperative 
residual refractive astigmatism in two groups of eyes with 
very similar preoperative refractive features. We are 
aware that the optical biometry measurements may have 
some limitations. However, in our subjects, the corneal 
curvature was homogeneous, and it allows a reliable and 
easy refractive acquisition, regardless of the operator 
effect. A limitation was that we did not conduct repeated 
follow-ups over a longer-term, whereas follow-up in 
previous reports was long or frequent [19-25, 36]. 
Nevertheless, the acquired refractive values remained 
constant. Another limitation of the study is that we did not 
assess overall patient satisfaction rates along with a check 
for preservation of fine stereopsis. However, 
postoperatively, no binocular symptoms or image 
distortion was reported by the study subjects. 
As a future direction, we suggest the need for well-
designed clinical research studies with longer follow-up 
periods and more sophisticated and detailed 
measurements and with more participants to confirm 
these findings. Furthermore, the current study examined 
different lenses implanted in one subject to evaluate eyes 
with very close biometric characteristics and the 
tolerability profile of low-power toric lenses. We suggest 
that the aberrometry value and contrast sensibility after 
implantation should be assessed to obtain more evidence-
based results and a better conclusion. The development 
of low-power toric IOLs may make it possible to correct 
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eyes with low amounts of corneal astigmatism without 
resorting to intraoperative or secondary surgical 
adjustments, or to other forms of treatment at a later 
time, to benefit optical independence after cataract 
surgery. Evidence of good refractive outcomes and a high 
degree of tolerability of low-power toric IOLs may suggest 
that implantation is suitable in all cases where spherical 
IOLs do not provide the required refractive and astigmatic 
correction meeting the patient's expectations. However, 
one should consider the cost-benefit of this implant for 
patients with low corneal astigmatism, as we found that 
UCDVA was not significantly different between toric IOL-
implanted eyes and spherical IOL-implanted fellow eyes. 
CONCLUSIONS  
To our knowledge, no previous study has sought to 
compare low-power toric IOLs and spherical IOLs in the 
fellow eyes of patients with low corneal astigmatism. Our 
findings suggest that low-power toric IOLs may result in 
good refractive and astigmatic outcomes as compared 
with spherical implanted fellow eyes, despite significant 
UCDVA improvement in both cases. Well-designed clinical 
research studies with longer follow-up periods and more 
participants are required to confirm these findings. 
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